Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula

Kirtee Wani; Nilesh Shah; Asmita Prabhune; Arun Jadhav; Prabhakar Ranjekar; Ruchika Kaul-Ghanekar

doi:10.1016/j.homp.2016.02.004

Homeopathy, Table of Contents

Homeopathy 2016; 105(04): 318-326
DOI: 10.1016/j.homp.2016.02.004

Original Paper

Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula

Authors

Kirtee Wani

¹Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University, Pune-Satara Road, Pune, 411043, Maharashtra, India
Nilesh Shah

²Homeopathy Medical College and Research Centre, Bharati Vidyapeeth University, Dhankawadi, Pune-Satara Road, Pune, 411043, Maharashtra, India
Asmita Prabhune

³Department of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, 411 008, Maharashtra, India
Arun Jadhav

²Homeopathy Medical College and Research Centre, Bharati Vidyapeeth University, Dhankawadi, Pune-Satara Road, Pune, 411043, Maharashtra, India
Prabhakar Ranjekar

¹Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University, Pune-Satara Road, Pune, 411043, Maharashtra, India
Ruchika Kaul-Ghanekar

¹Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University, Pune-Satara Road, Pune, 411043, Maharashtra, India

Subject Editor:

Abstract

Background: Breast cancer is the most common cancer diagnosed among women and is the second leading cause of cancer death. Homeopathic medicines are part of the alternative medicines that are given as a supportive therapy in breast cancer. The objective of this study was to investigate the anticancer activity of commercially available homeopathic preparations of Terminalia chebula (TC) and evaluate their nanoparticulate nature.

Methods: Mother tincture (MT) and other homeopathic preparations (3X, 6C and 30C) of TC were tested for their effect on the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell growth assay was performed to analyze the effect of the different potencies on the growth kinetics of breast cancer cells. MT and 6C were evaluated for the presence of nanoparticles by using scanning electron microscopy (SEM) and transmission electron microscopy (TEM).

Results: MT decreased the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cells. However, the other potencies (3X, 6C and 30C) decreased the viability of only breast cancer cells without affecting the viability of the non-cancerous cells. All the potencies, MT, 3X, 6C and 30C, reduced growth kinetics of breast cancer cells, more specifically at 1:10 dilution at 24, 48 and 72 h. Under SEM, MT appeared as a mesh-like structure whereas under TEM, it showed presence of nanoclusters. On the other hand, 6C potency contained 20 nm sized nanoparticles.

Conclusion: The current study reports the anticancer activity of homeopathic preparations of TC against breast cancer and reveals their nanoparticulate nature. These preliminary results warrant further mechanistic studies at both in vitro and in vivo levels to evaluate the potential of TC as nanomedicine in breast cancer.

Keywords

Terminalia chebula - Homeopathic preparations - Anticancer activity - Nanoparticles

Full Text

References

References
1 Patnaik J.L., Byers T., DiGuiseppi C., Dabelea D., Denberg T.D. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer. Breast Cancer Res 2011; 13: 1-9.
2 Devi B., Bodh K., Kumari N. et al. Awareness and prevalence of risk factors of breast cancer and cervix cancer among women more than 35 years of age residing in low socio income colony. IJON 2015; 1: 1-10.
3 Liao G.S., Apaya M.K., Shyur L.F. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Altern Med 2013; 2013: 1-17.
4 Khuda-Bukhsh A.R., Bhattacharyya S.S., Paul S., Dutta S., Boujedaini N., Belon P. Modulation of signal proteins: a plausible mechanism to explain how a potentized drug secale cor 30c diluted beyond Avogadro's limit combats skin papilloma in mice. Evid Based Complement Altern Med 2011. 286320.
5 Bhattacharyya S.S., Mandal S.K., Biswas R. et al. In vitro studies demonstrate anticancer activity of an alkaloid of the plant Gelsemium sempervirens . Exp Biol Med (Maywood) 2008; 233: 1591-1601.
6 Saha S., Bhattacharjee P., Guha D. et al. Sulphur alters NFkappaB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. Int J Oncol 2015. 10.3892/ijo.2015.3061.
7 Saha S., Hossain D.M., Mukherjee S. et al. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit. BMC Complement Altern Med 2013; 13: 230.
8 Demangeat J.L. Nanosized solvent superstructures in ultramolecular aqueous dilutions: twenty years' research using water proton NMR relaxation. Homeopathy 2013; 102: 87-105.
9 Elia V., Ausanio G., Gentile F., Germano R., Napoli E., Niccoli M. Experimental evidence of stable water nanostructures in extremely dilute solutions, at standard pressure and temperature. Homeopathy 2014; 103: 44-50.
10 Konovalov A.I., Ryzhkina I.S. Highly diluted aqueous solutions: formation of nano-sized molecular assemblies (nanoassociates). Geochem Int 2014; 52: 1207-1226.
11 Chikramane P.S., Kalita D., Suresh A.K., Kane S.G., Bellare J.R. Why extreme dilutions reach non-zero asymptotes: a nanoparticulate hypothesis based on froth flotation. Langmuir 2012; 28: 15864-15875.
12 Chikramane P.S., Suresh A.K., Bellare J.R., Kane S.G. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010; 99 (04) 231-242.
13 Bell I.R., Sarter B., Standish L.J., Banerji P., Banerji P. Low doses of traditional nanophytomedicines for clinical treatment: manufacturing processes and nonlinear response patterns. J Nanosci Nanotechnol 2015; 15: 4021-4038.
14 Rajendran E.S. Field emission scanning electron microscopic (FESEM) and energy dispersive spectroscopic (EDS) studies of centesimal scale potencies of the homeopathic drug Lycopodium clavatum . Am J Homeopath Med 2015; 108: 9-18.
15 Barve R., Chaughule R. Size-dependent in vivo/in vitro results of homoeopathic herbal extracts. J Nanostruct Chem 2013; 3: 18.
16 Bell I.R., Muralidharan S., Schwartz G.E. Nanoparticle characterization of traditional homeopathically-manufactured Gelsemium sempervirens medicines and placebo controls. J Nanomed Biotherapeutic Discov 2015; 6: 1000136.
17 Ghosh S., Chakraborty M., Das S., Basu R., Nandy P. Effect of different potencies of nanomedicine Cuprum metallicum on membrane fluidity-a biophysical study. Am J Homeopath Med 2015; 107: 161-169.
18 Rajendran E.S. An evaluation of Avogadro's number in the light of HRTEM and EDS studies of high dilutions of Ferrum metallicum 6, 30, 200, 1M, 10M and 50 Mc. Int J High Dilution Res 2015; 14: 3-9.
19 Bell I.R., Muralidharan S., Schwartz G.E. Nanoparticle characterization of traditional homeopathically-manufactured silver (Argentum Metallicum) medicines and placebo controls. J Nanomed Nanotechnol 2015; 6: 311.
20 Chaudhary A. Ayurvedic bhasma: nanomedicine of ancient India–its global contemporary perspective. J Biomed Nanotechnol 2011; 7 (01) 68-69.
21 Vallance A.K. Can biological activity be maintained at ultra-high dilution? An overview of homeopathy, evidence, and bayesian philosophy. J Altern Complement Med 2008; 4 (01) 49-76.
22 http://www.ccrhindia.org/common_indian_plants/L22.htm by Central Council of Research in Homeopathy.
23 Suryaprakash D.V., Sreesatya N., Avanigadda S., Vangalapati M. Pharmacological review on Terminalia chebula . IJRPBS 2012; 3 (02) 679-683.
24 Rathinamoorthy R., Thilagavathi G. Terminalia chebula – review on pharmacological and biochemical studies. IJPRIF 2014; 6 (01) 97-116.
25 Bag A., Kumar Bhattacharyya S., Kumar Pal N., Ranjan Chattopadhyay R. Anti-inflammatory, anti-lipid peroxidative, antioxidant and membrane stabilizing activities of hydroalcoholic extract of Terminalia chebula fruits. Pharm Biol 2013; 51 (12) 1515-1520.
26 Kannan P., Ramadevi S.R., Hopper W. Antibacterial activity of Terminalia chebula fruit extract. Afr J Microbiol Res 2009; 3 (04) 180-184.
27 Shinde S.L. The antifungal activity of five Terminalia species checked by paper disc method. IJPRD 2011; 3 (02) 0974-9446.
28 Ahn M.J., Kim C.Y., Lee J.S. et al. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis . Planta Med 2002; 68 (05) 457-459.
29 Ma H., Diao Y., Zhao D., Li K., Kang T. A new alternative to treat swine influenza A virus infection: extracts from Terminalia chebula Retz. Afr J Microbiol Res 2010; 4 (06) 497-499.
30 Debnath J., Tigari P., Karki R., Kotresha D., Sharma P. An experimental evaluation of anti-stress effects of Terminalia chebula . J Physiol Biomed Sci 2011; 24 (02) 13-19.
31 Rao N.K., Nammi S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 2006; 7: 6-17.
32 Saleem A., Husheem M., Härkönen P., Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol 2002; 81 (03) 327-336.
33 Ahuja R., Agrawal N., Mukerjee A. Evaluation of anticancer potential of Terminalia chebula fruits against Ehrlich Ascites Carcinoma induced cancer in mice. JSIR 2013; 2 (03) 549-554.
34 Frass M., Friehs H., Thallinger C. et al. Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients – a pragmatic randomized controlled trial. Complement Ther Med 2015; 23 (03) 309-317.
35 Milazzo S., Russell N., Ernst E. Efficacy of homeopathic therapy in cancer treatment. Eur J Cancer 2006; 42: 282-289.
36 Aust N. Prolonged lifetime by adjunct homeopathy in cancer patients—a case of immortal time bias. Complement Ther Med 2016; 24: 80.
37 Ciocca D.R., FuMTua S., Lock-Lim S., Toft D.O., Welch W.J., McGuire W.L. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 1992; 52: 1648-3654.
38 Shirali A.C., Look M., Du W. et al. Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival. Am J Transpl 2011; 11: 2582-2592.
39 Prakash D.J., Arulkumar S., Sabesan M. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stress induced behavioral and biochemical alteration in male albino mice. Pharmacogn Res 2010; 2: 330-334.
40 Cucherat M., Haugh M.C., Gooch M., Boissel J.P. Evidence of clinical efficacy of homeopathy. Eur J Clin Pharmacol 2000; 56 (01) 27-33.
41 Riley D., Fischer M., Singh B., Haidvogl M., Heger M. Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. J Altern Complement Med 2001; 7 (02) 149-159.
42 Pinjari D.V., Pandit A.B. Cavitation milling of natural cellulose to nanofibrils. Ultrason Sonochem 2010; 17: 845-852.
43 Zheng Z., Zhang X., Carbo D., Clark C., Nathan C., Lvov Y. Sonication-assisted synthesis of polyelectrolyte-coated curcumin nanoparticles. Langmuir 2010; 26: 7679-7681.